Real-life data on the treatment of diabetic macular oedema with fluocinolone acetonide presented
This year's 19th G.I.Vre National Congress was held in Florence, 7-9 June, at the Palazzo dei Congressi, housed in the 19th-century Villa Vittoria. Born in 1999, the Italian Vitreoretinal Surgery Group (G.I.Vre) has always been an important point of reference for Italian retina specialists. The Society now has 300 members and every year organises a national congress, which has now exceeded 1000 participants.
This year's edition was organised by Professors Marco Borgioli, Augusto Morocutti and Stanislao Rizzo.
In the rich programme of the congress, the symposium focusing on the treatment of diabetic macular oedema was particularly successful.
Three-year data from 'real life' studies on the use of fluocinolone acetonide in the treatment of diabetic macular oedema were presented at the event.
NEW REAL-LIFE MILESTONES IN THE MANAGEMENT OF THE PATIENT WITH DIABETIC MACULAR OEDEMA
– Evolving clinical management of EMD. What fluocinolone acetonide implantation can offer
Prof. F. Boscia
– Fluocinolone acetonide in clinical practice, the San Raffaele experience
Prof. F. Bandello
– Real World Experience from Germany - 3 years data
Dr. Ramin Khoramnia
– Cortisone and hypertone: Follow-up management Q&A
Prof. C. Traverso
8 June 2018 h. 12.30 - 13.30
CENTRAL HALL 1
PALAZZO DEGLI AFFARI, Florence
 
Dr. Carmelo Chines
Direttore responsabile
English 
Italian